SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4) inhibits macrophage adhesion to vascular smooth muscle cells
-
Add time:09/29/2019 Source:sciencedirect.com
Inflammation in de-endothelialised arteries contributes to the development of cardiovascular diseases. The process that initiates this inflammatory response is the adhesion of monocytes/macrophages to exposed vascular smooth muscle cells, typically stimulated by cytokines such as tumour necrosis factor-α (TNF). The aim of this study was to determine the effect of the sphingolipid SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4) (SPC) on the interaction of monocytes/macrophages with vascular smooth muscle cells. Rat aortic smooth muscle cells and rat bone marrow-derived macrophages were co-cultured using an in vitro assay following incubation with sphingolipids to assess inter-cellular adhesion. We reveal that SPC inhibits the TNF-induced adhesion of macrophages to smooth muscle cells. This anti-adhesive effect was the result of SPC-induced changes to the smooth muscle cells (but not the macrophages) and was mediated, at least partly, via the sphingosine 1-phosphate receptor subtype 2. Lipid raft domains were also required. Although SPC did not alter expression or membrane distribution of the adhesion proteins intercellular adhesion molecule-1 and vascular cellular adhesion protein-1 in smooth muscle cells, SPC preincubation inhibited the TNF-induced increase in inducible nitric oxide synthase (NOS2) resulting in a subsequent decrease in nitric oxide production. Inhibiting NOS2 activation in smooth muscle cells led to a decrease in the adhesion of macrophages to smooth muscle cells. This study has therefore delineated a novel pathway which can inhibit the interaction between macrophages and vascular smooth muscle cells via SPC-induced repression of NOS2 expression. This mechanism could represent a potential drug target in vascular disease.
We also recommend Trading Suppliers and Manufacturers of SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4). Pls Click Website Link as below: cas 1670-26-4 suppliers
Prev:Regulation of ryanodine receptors by SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4): Involvement of both calmodulin-dependent and -independent mechanisms
Next:Effect of direct albumin binding to SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4) in Jurkat T cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effect of direct albumin binding to SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4) in Jurkat T cells09/30/2019
- Regulation of ryanodine receptors by SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4): Involvement of both calmodulin-dependent and -independent mechanisms09/28/2019
- Short communicationThe critical micelle concentrations of lysophosphatidic acid and SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4)10/01/2019
- Novel effects of SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4) on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to WNT activation09/27/2019
- ReviewThe multi-functional role of SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4)09/26/2019
- SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4) protects cardiomyocytes against ischemic apoptosis via lipid raft/PTEN/Akt1/mTOR mediated autophagy09/25/2019
- SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4) regulates the Hippo signaling pathway in a dual manner09/24/2019
- SPHINGOSYLPHOSPHORYLCHOLINE (cas 1670-26-4)09/10/2019